Drupal.behaviors.print = function(context) {window.print();window.close();}>
Med BioGene Extends Lung Cancer Biomarker Deal with UHN
March 18, 2009
Med BioGene Extends Lung Cancer Biomarker Deal with UHN
By a GenomeWeb staff reporter
The expanded deal will provide Med Biogene with additional markers for its LungExpress Dx test.
Full-text access for registered users only.
Existing users
login here
.
New to GenomeWeb?
Register here
quickly for free access.
Related Stories
Med BioGene Amends Licensing Deal with Precision; Updates Litigation Status
October 3, 2012 / GenomeWeb Daily News
Med BioGene Shareholders Approve Commercialization Deal with Precision Therapeutics
April 13, 2011 / GenomeWeb Daily News
UPDATE: Signal Genetics Makes Improved Offer to Market Med BioGene Test
March 23, 2011 / GenomeWeb Daily News
Med BioGene Inks LungExpress Alliance with Precision Therapeutics
March 1, 2011 / GenomeWeb Daily News
Med BioGene Loss Shrinks as It Prepares Lung Test Launch
April 30, 2009 / GenomeWeb Daily News